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In this article, I argue for a reconceptualization of major depressive disorder (major depression) as an infectious
disease. I suggest that major depression may result from a parasitic, bacterial, or viral infection and present
examples that illustrate possible pathways by which these microorganisms could contribute to the etiology of
major depression. I also argue that the reconceptualization of the human body as an ecosystem for these
microorganisms and the human genome as a host for non-human exogenous sequences may greatly amplify the
opportunity to discover genetic links to the illness. Deliberately speculative, this article is intended to stimulate
novel research approaches and expand the circle of researchers taking aim at this vexing illness.
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Despite decades of substantial research efforts, major de-
pressive disorder (MDD) remains among the most com-
mon mental disorders, with a 16.6% lifetime prevalence
rate [1]. Pharmacological treatment approaches have not
changed during this period, targeting primarily receptor-
ligand interactions [2]. These types of antidepressants
may bring relief to patients with severe symptoms but are
not clinically more effective than placebos in mild to mod-
erate cases [3]. Indeed, recurrence rates of 50% for first-
episode patients and of 80% for second-episode patients
[4] suggest that the core of the illness goes untreated.
Given this track record, I argue that it is time for an
entirely different approach. Instead of conceptualizing
MDD as an emotional disorder, I suggest to reconceptu-
alize it as some form of an infectious disease. I propose
that future research should conduct a concerted search
for parasites, bacteria, or viruses that may play a causal
role in the etiology of MDD. I present three arguments
why this may be a fruitful endeavor. I have outlined the
idea in much greater detail elsewhere [5], but will high-
light some key points here.Correspondence: turhan.canli@stonybrook.edu
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My first argument is that patients with MDD exhibit
sickness behavior. Patients experience loss of energy;
they commonly have difficulty getting out of bed and
lose interest in the world around them. Although our
Western conceptualization puts affective symptoms
front-and-center, non-Western patients who meet DSM
criteria for major depression report primarily somatic
symptoms [6-11], reflecting in part cultural differences
in the stigmatization of mental illness.
Yet, studies of inflammatory biomarkers in major de-
pression strongly suggest an illness-related origin. For ex-
ample, a meta-analysis of 24 studies confirmed prior
reports of elevated TNFα and IL-6 in patients with major
depression [12]. A second meta-analysis of 29 studies fur-
ther extended the list of significantly elevated inflamma-
tory markers to also include the soluble interleukin-2
receptor [13].
Several postmortem studies report the presence of in-
flammatory markers in the brains of depressed or mood-
disordered patients. For example, compared to controls,
female suicide victims showed elevated levels of IL-4 and
male suicide victims showed elevated levels of IL-13 in
Brodmann Area (BA) 11 [14], a brain region previously
associated with suicidal ideation [15,16]. Compared to
age-matched controls, patients diagnosed with major de-
pression showed elevated levels of transmembrane TNFα
(tmTNFα) in BA46 [17], a region associated with emotionis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Canli Biology of Mood & Anxiety Disorders 2014, 4:10 Page 2 of 5
http://www.biolmoodanxietydisord.com/content/4/1/10regulation [18-20]. Patients with major depression, relative
to controls, showed differential expression of a large set of
both anti- and pro-inflammatory markers (including IL1α,
2, 3, 5, 8, 9, 10, 12A, 13, 15, 18, and IFNγ) in BA10 [21], a
region associated with reward processing [22].
These inflammatory markers may represent activation
of the immune system in response to some kind of
pathogen, which could be a parasite, bacterium, or virus,
and which could play a causal role in the etiology of de-
pression. There is currently no direct evidence that
major depression is caused by such microorganisms, but
nature has offered some examples to illustrate that such
a process is conceivable.
Thus, my second argument is that nature has already
provided examples by which parasites, bacteria, or vi-
ruses can affect emotional behavior. The best-known ex-
ample of a parasite that affects emotional behavior and
that is relevant to human health is Toxoplasma gondii.
T. gondii lives in the feline intestinal tract, where it lays
its eggs, which are dispersed into the environment upon
excretion. When a rat comes in contact with these eggs
and becomes infected, it becomes attracted to the scent
of cat urine [23,24]. This manipulation of the rat’s be-
havior involves the deposit of parasitic cysts across the
rodent brain including the amygdala [25]. The mechan-
ism for loss of fear to the scent of cat urine appears to
involve a reduction in circulating corticosterone and
dendritic retraction in the basolateral amygdala [26].
The mechanism for the rat’s attraction to the odor may
involve activation of sexual arousal pathways [27].
The specificity of the behavioral change in the rat’s be-
havior appears to reflect functional changes that are lim-
ited to catecholaminergic neurons [28]. Infected animals
have elevated levels of dopamine [29], but T. gondii can
only synthesize tyrosine hydroxylase (which converts tyro-
sine to L-DOPA), and would therefore need to rely on cat-
echolaminergic neurons to provide the needed DOPA
decarboxylase to convert the L-DOPA to dopamine.
Human exposure to T. gondii is pervasive, with one-
third of the world’s population [30] and one-fifth of the
U.S. population [31] believed to be infected. Infection is
associated with elevated inflammatory cytokines IL-6,
IL-12, TNF, and IFN-γ [32,33], similarly as observed in de-
pressed patients. A study of 20 European countries re-
ported a positive correlation between T. gondii prevalence
rates and national suicide rates [34]. Among patients with
diagnosed major depression or bipolar disorder, those with
a history of suicide attempt had higher T. gondii antibody
titers [35]. Yet, large-scale studies of major depression and
T. gondii or systematic searches to discover other potential
parasitic infections have not yet been conducted.
Bacteria could be another causal factor for major de-
pression. Studies of bacterial colonies residing in the
gastrointestinal tract have begun to examine links toemotional behavior. In the first study of this kind, germ-
free (GF), specific pathogen-free (SPF), and gnotobiotic
mice were compared in their response to restraint stress
[36]. GF mice exhibited higher levels of plasma ACTH
and corticosterone and had lower levels of brain-derived
neurotrophic factor in the cortex and hippocampus, com-
pared to SPF mice. The elevated stress response of GF
mice was normalized with administration of the bacterium
Bifidobacterium infantis. Another rodent study showed
that administration of B. infantis in rats reduced the levels
of IFN-γ, TNF-α, and IL-6 following mitogen stimulation
and altered tryptophan, 5-HIAA, and DOPAC levels in
the frontal cortex and amygdala [37]. Administration of
the Lactobacillus rhamnosus strain in mice was shown to
alter GABAergic expression in the brain: elevating
GABAB1b mRNA in the cingulate and prelimbic cortices,
while reducing it in hippocampus and amygdala, among
other regions [38].
The ‘leaky gut’ hypothesis proposes a mechanism by
which gastrointestinal bacteria may contribute to major
depression [39,40]. According to this hypothesis, cyto-
kines or other stressors may render the intestinal tract
permeable to lipopolysaccharides (LPS) from gram-
negative bacteria to activate the immune system. Indeed,
the model is supported by data showing elevated serum
concentrations of IgM and IgA against LPS of the gram-
negative enterobacteria in depressed patients [39,40].
These studies were conducted with relatively small num-
bers of patients and suggested that this mechanism may
apply to some subgroups of patients but not others. It
would be useful to expand the search using large patient
cohorts and a wide range of different antibodies. Future
work should then examine potential neural mechanisms.
Viruses represent the third pathogenic route in the eti-
ology of major depression. A meta-analysis of 28 studies
explicitly examined the link between infectious agents
and depression [41]. Among viruses that had significant
associations with the illness were the Borna disease virus
(BDV), herpes simplex virus-1, varicella zoster virus, and
Epstein-Barr virus. Among these, BDV has been studied
most extensively and was 3.25 times more likely to be
found in depressed patients than in normal controls
[41]. One postmortem study reported BDV infection in
2 out of 30 depressed patients in the frontal and tem-
poral cortex, olfactory bulb, and hippocampus [42], al-
though a larger study failed to detect any infection [43].
A small open-label study of BDV-infected depressed pa-
tients reported a reduction in both depressive symptoms
and BDV infection upon treatment with the antiviral
drug amantadine [44].
The mechanism between BDV infection and depres-
sion could involve glutaminergic transmission, because
amantadine is an antagonist of the N-methyl-D-aspartate
(NMDA) receptor, one of the receptors targeted by
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has been evaluated in a randomized, double-blind study
of patients diagnosed with bipolar depression, where it
was applied to augment treatment with the presynaptic
glutamate release inhibitor lamotrigine, and found to
accelerate treatment response [45]. Another NMDA
receptor antagonist, ketamine, also has antidepressant
effects [46], which appear to be mediated by changes in
mTOR signaling [47]. However, the literature on BDV
infection and depression remains controversial, with
several studies failing to replicate any association be-
tween the two [48-51].
My third argument is that reconceptualizing major de-
pression as being causally linked to parasites, bacteria,
or viruses is useful when thinking about the genetics of
this illness. Evidence from twin studies notwithstanding,
the search for specific genes linked to major depression
has come up empty [52,53]. Perhaps, we have been look-
ing at the wrong organism. Genetic studies to date have
focused the search on human genes within our genome.
Yet, 8% of the human genome is based on exogenous se-
quences from retroviruses [54]. These retroviral inser-
tions may sometimes benefit the human host and
therefore be protected from mutational degeneration
[55]. Indeed, the BDV discussed earlier inserted some of
its sequences into vertebrate genomes approximately 40
million years ago [56], and presence of these sequences
correlates with disease resistance to BDV. Parasites
could also add exogenous sequences to the human gen-
ome through the process of horizontal gene transfer
[57]. It is possible that polymorphisms within such ex-
ogenous sequences, or interactions between these ex-
ogenous sequences and other variables such as human
gene polymorphisms or stressful life experiences, could
render some individuals vulnerable to major depression.
Furthermore, if we view the human body as an ecosys-
tem that is a host to numerous microorganisms which
may be passed across generations, the opportunity for
genetic discoveries is vastly amplified. For example, an
estimated thousand species of bacteria reside in the hu-
man gastrointestinal tract [58], and these could be passed
during birth or through common environmental exposure
between parents and offspring [59]. Humans also carry
vast numbers of viruses, which can be unknown and go
undetected until subjected to a concerted search using
new approaches such as deep sequencing [60].
Conclusions
In light of the above considerations, an important point of
reflection concerns the relation between the immune re-
sponse and MDD and the specificity of any putative mech-
anism. The literature implicating the immune system in
MDD [61] can be read as suggesting that the immune re-
sponse itself is the causal mechanism in depression.Indeed, conditions such as hypoxia known to produce
sterile inflammation ([62], i.e., activation of the immune
system sans a pathogen) may increase the risk of depres-
sion [61] in conditions such as obstructive sleep apnea
[63] or chronic obstructive pulmonary disease [64]. Yet,
most cases of MDD are not attributable to sterile inflam-
mation. Thus, I suggest that some unknown pathogen(s)
could play a causal role, and that the immune response is
secondary to the infection; interventions that only target
the immune response may bring symptom relief but
would not address the root cause of the illness.
If a pathogen played a causal role in MDD, the next
question would concern the specificity of the mech-
anism. One perspective would favor a very general,
non-specific mechanism. For example, chronic fatigue
syndrome (CFS)—which is characterized by sickness be-
havior that may include depressive symptoms—has been
hypothesized to be caused by vagus nerve infection, re-
gardless of the type of pathogen [65]. My view is that,
for MDD, the type of pathogen may matter a great
deal, and that it plays a very specific causal role: the ex-
amples I presented above suggest plausible mechanisms
by which pathogens may alter neurotransmission. How-
ever, there may not be a single pathogen that causes
all cases of MDD. Instead, there may be a class of path-
ogens, similar to those discussed above, which share
common modes of action. This class of pathogens
would specifically target the nervous system in a man-
ner that causally contributes to MDD. I use the term
‘contribute’ to indicate that these pathogens may act in
concert with other variables. For example, an individual
may carry a latent infection and be asymptomatic for
depressive symptoms. This individual would be cha-
racterized by susceptibility to MDD which may only
emerge after the pathogen was activated by other fac-
tors such as stressful life events; this activation could
then also trigger a concomitant immune response. It is
possible that such a pathogen-driven mechanism is not
limited to MDD but may contribute to other psychopa-
thologies. For example, posttraumatic stress disorder
could be one such extension of the same mechanism:
not every individual develops the disorder in response
to a traumatic experience (suggesting individual differ-
ences in susceptibility), and the illness is accompanied
by immune system activation [66,67].
In closing, I think it would be worthwhile to conduct
large-scale studies of carefully characterized depressed
patients and healthy controls, using gold-standard clin-
ical and infectious disease-related study protocols, as
have already been developed for bacteria [68,69] and vi-
ruses [70-76]. Such efforts, if successful, would represent
the ‘end of the beginning’, as any such discovery would
represent the first step toward developing a vaccination
for major depression.
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